Lidanserin

Lidanserin (INN; ZK-33,839) is a drug which acts as a combined 5-HT2A and α1-adrenergic receptor antagonist.[1][2] It was developed as an antihypertensive agent but was never marketed.[1][2]

Lidanserin
Clinical data
ATC code
  • None
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC26H31FN2O4
Molar mass454.542 g·mol−1
3D model (JSmol)

See also

References

  1. Richard C. Allen (1989). Annual Reports in Medicinal Chemistry. Academic Press. p. 56. ISBN 978-0-12-040524-4. Retrieved 6 May 2012.
  2. American Chemical Society; American Chemical Society. Chemical Abstracts Service (27 February 1989). Chemical abstracts. American Chemical Society. p. 114. Retrieved 6 May 2012.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.